US Genomics announced today the availability of its Direct miRNA reagents and kits to detect known human and mouse micro RNAs with the company’s Trilogy Single Molecule Analyzer platform.

The Trilogy platform directly detects and quantifies individual molecules of miRNAs, DNA, RNA, and proteins without need for amplification, US Genomics said. The newly available Direct miRNA kits enable researchers to screen samples against a panel of known miRNAs, and to validate and characterize specific miRNAs of interest, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.